Polaris Market Research releases its new research report on the minimal residual disease (MRD) market, which provides comprehensive insight into the current market landscape and future outlook. It discusses the major forces driving growth, including the rising global cancer burden, the shift toward precision oncology, and continuing advances in next-generation sequencing (NGS) and liquid...
Polaris Market Research presents its latest market research report, titled Minimal Residual Disease (MRD) Market Size, Share, Trends & Forecast, 2026-2034. It is a comprehensive market research report analyzing the fast-evolving minimal residual disease (MRD) market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive...
The global Minimal Residual Disease Market was valued at USD 2.53 billion in 2024 and is projected to reach USD 9.16 billion by 2034, exhibiting a CAGR of 13.7% during the forecast period. The market is being fueled by rising prevalence of hematologic malignancies, technological advancements in molecular diagnostics, and increasing adoption...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek